Cite

HARVARD Citation

    Rowe, M. et al. (2021). A Multicentre Retrospective Analysis of Toxicity in 6-weekly Versus 3-weekly Pembrolizumab. Journal of immunotherapy. 44 (4), p. . [Online]. 
  
Back to record